Inhibrx Biosciences Inc. (INBX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Inhibrx Biosciences Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$73.29
−23.38% today
Market cap
$1.4B
Overall quality
—
Kronos AI 30-day
−6.5%
2 of 8 simulated paths end higher
Inhibrx Biosciences Inc. (INBX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $1.4B. It trades at $73.29, down 23.38% today. 3 analysts' average target of $266.67 implies +263.9% from today's price. Kronos AI's 30-day forecast is −6.5% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $266.67 |
| Low – high | $230.00 – $325.00 |
| Analysts | 3 |
| Upside to average | +263.9% |
Kronos AI 30-day forecast
| Expected close | $89.48 (−6.5%) |
| Likely range | −8.6% … +6.8% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.